A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT07234591 · RECRUITING
Trial details
- NCT number
- NCT07234591
- Sponsor
- Usynova Pharmaceuticals Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-21
- Primary completion
- 2026-04-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.